123-I ioflupane (Datscan®) presynaptic nigrostriatal imaging in patients with movement disorders
Braz. arch. biol. technol
;
48(spe2): 115-126, Oct. 2005. tab, ilus
Article
Dans Anglais
| LILACS
| ID: lil-448897
ABSTRACT
123-I Ioflupane (Datscan®) presynaptic imaging has been shown to have a significant utility in the assessment of patients with movement disorders 123-I Ioflupane SPECT is able to distinguish between ParkinsonÆs disease (PD) and other forms of parkinsonism without degeneration of the nigrostriatal pathway, including a common movement disorder such as essential tremor, and to assess disease progression in PD and other neurodegenerative disorders involving the substantia nigra.
RESUMO
A imagem pré-sináptica através de 123-I Ioflupane (Datscan®) tem mostrado um papel significante na avaliação de pacientes com distúrbios do movimento. 123-I Ioflupane SPECT é capaz de distinguir entre Mal de Parkinson (MP) e outras formas de parkinsonismo sem degenerações da via nigroestriatal incluindo um distúrbio comum de movimento parecido com o tremor essencial e para medir a evolução da doença no Mal de Parkinson e outros distúrbios neurodegenerativos envolvendo a substantia nigra.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
langue:
Anglais
Texte intégral:
Braz. arch. biol. technol
Thème du journal:
Biologie
Année:
2005
Type:
Article
Pays d'affiliation:
Espagne
Institution/Pays d'affiliation:
Tomelloso+ES
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS